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Background: Constrictive pericarditis (CP) may develop following pericardiocentesis, but the incidence and prognosis of CP after 
pericardiocentesis has not been studied yet. The aim of this study was to investigate the incidence and outcomes of CP after pericardiocentesis for 
significant pericardial effusion (PE). 
Methods: A total of 205 consecutive patients (59.1±16.7 years, 94 males) who underwent pericardiocentesis and had follow-up (FU) 
echocardiography were enrolled. CP was diagnosed by demonstrating typical Doppler and 2D echocardiographic findings of the exaggerated 
ventricular interdependence and the dissociation of intrathoracic and intracardiac pressures. 
Results: The causes of PE were idiopathic or post-viral pericarditis (66 cases, 32.2%), post-cardiac surgery (59 cases, 28.8%), acute procedural 
hemorrhagic tamponade (33 cases, 16.1%), malignancy (24 cases, 11.7%), connective tissue disease (9 cases, 4.4%), uremia (8 cases, 3.9%), 
and miscellaneous (6 cases, 2.9%). Typical echocardiographic evidence of CP was observed in 33 patients (16.1%) (12 idiopathic or post-viral 
pericarditis, 11 acute procedural hemorrhagic tamponade, 6 post-cardiac surgery, 4 miscellaneous), and the CP was developed within 1 week 
(2.1±1.6 days) after pericardiocentesis except for one case. CP was treated by anti-inflammatory agents in 15 patients and conservatively in 18 
patients. During clinical (14.5±11.0 months) and echocardiographic FU (6.7±9.8 months) in CP patients, 4 patients were died. CP was improved 
and did not recur in 28 patients with anti-inflammatory therapy or spontaneously. One patient who showed persistent constrictive physiology and 
symptoms despite of anti-inflammatory therapy underwent pericardiectomy. 
Conclusion: The present study demonstrated that CP is not a rare complication after pericardiocentesis for PE, usually develops in the early 
clinical course after pericardiocentesis, and mostly transient in nature. A trial of anti-inflammatory or conservative medical therapy should be 
considered in patients with CP after pericardiocentesis before performing surgical pericardiectomy.
